Escalon Medical Statistics
Total Valuation
Escalon Medical has a market cap or net worth of 1.12 million. The enterprise value is 1.81 million.
| Market Cap | 1.12M |
| Enterprise Value | 1.81M |
Important Dates
The next estimated earnings date is Friday, September 27, 2024.
| Earnings Date | Sep 27, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Escalon Medical has 7.42 million shares outstanding. The number of shares has decreased by -38.01% in one year.
| Shares Outstanding | 7.42M |
| Shares Change (YoY) | -38.01% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | n/a |
| Float | 7.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.10 |
| PB Ratio | 1.09 |
| P/FCF Ratio | 18.35 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.34, with an EV/FCF ratio of 29.73.
| EV / Earnings | -6.11 |
| EV / Sales | 0.16 |
| EV / EBITDA | 5.34 |
| EV / EBIT | n/a |
| EV / FCF | 29.73 |
Financial Position
The company has a current ratio of 1.58, with a Debt / Equity ratio of 36.66.
| Current Ratio | 1.58 |
| Quick Ratio | 0.73 |
| Debt / Equity | 36.66 |
| Debt / EBITDA | 1.81 |
| Debt / FCF | 10.07 |
| Interest Coverage | -1.61 |
Financial Efficiency
Return on equity (ROE) is -3.59% and return on invested capital (ROIC) is -0.95%.
| Return on Equity (ROE) | -3.59% |
| Return on Assets (ROA) | -0.49% |
| Return on Capital (ROIC) | -0.95% |
| Revenue Per Employee | 306,456 |
| Profits Per Employee | -7,808 |
| Employee Count | 38 |
| Asset Turnover | 2.40 |
| Inventory Turnover | 3.75 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.50% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -62.50% |
| 50-Day Moving Average | 0.13 |
| 200-Day Moving Average | 0.21 |
| Relative Strength Index (RSI) | 61.10 |
| Average Volume (20 Days) | 1,949 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.01 |
Income Statement
In the last 12 months, Escalon Medical had revenue of 11.65 million and -296,711 in losses. Loss per share was -0.04.
| Revenue | 11.65M |
| Gross Profit | 5.13M |
| Operating Income | -37,892 |
| Pretax Income | -61,309 |
| Net Income | -296,711 |
| EBITDA | -351 |
| EBIT | -37,892 |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 564,707 in cash and 614,130 in debt, giving a net cash position of -49,423 or -0.01 per share.
| Cash & Cash Equivalents | 564,707 |
| Total Debt | 614,130 |
| Net Cash | -49,423 |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | 1.68M |
| Book Value Per Share | 0.14 |
| Working Capital | 1.52M |
Cash Flow
In the last 12 months, operating cash flow was 92,027 and capital expenditures -31,038, giving a free cash flow of 60,989.
| Operating Cash Flow | 92,027 |
| Capital Expenditures | -31,038 |
| Free Cash Flow | 60,989 |
| FCF Per Share | 0.01 |
Margins
Gross margin is 44.07%, with operating and profit margins of -0.33% and -0.53%.
| Gross Margin | 44.07% |
| Operating Margin | -0.33% |
| Pretax Margin | -0.53% |
| Profit Margin | -0.53% |
| EBITDA Margin | -0.00% |
| EBIT Margin | -0.33% |
| FCF Margin | 0.52% |
Dividends & Yields
Escalon Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 38.01% |
| Shareholder Yield | 38.01% |
| Earnings Yield | -26.52% |
| FCF Yield | 5.45% |
Stock Splits
The last stock split was on November 24, 1997. It was a reverse split with a ratio of 0.25.
| Last Split Date | Nov 24, 1997 |
| Split Type | Reverse |
| Split Ratio | 0.25 |
Scores
Escalon Medical has an Altman Z-Score of -17.65. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -17.65 |
| Piotroski F-Score | n/a |